199 related articles for article (PubMed ID: 7682102)
1. Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2.
Mulligan LM; Gardner E; Smith BA; Mathew CG; Ponder BA
Genes Chromosomes Cancer; 1993 Mar; 6(3):166-77. PubMed ID: 7682102
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity on the long arm of chromosome 22 in pheochromocytoma.
Tanaka N; Nishisho I; Yamamoto M; Miya A; Shin E; Karakawa K; Fujita S; Kobayashi T; Rouleau GA; Mori T
Genes Chromosomes Cancer; 1992 Nov; 5(4):399-403. PubMed ID: 1283329
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
Khosla S; Patel VM; Hay ID; Schaid DJ; Grant CS; van Heerden JA; Thibodeau SN
J Clin Invest; 1991 May; 87(5):1691-9. PubMed ID: 2022740
[TBL] [Abstract][Full Text] [Related]
4. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
[TBL] [Abstract][Full Text] [Related]
5. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
[TBL] [Abstract][Full Text] [Related]
6. Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A.
Lairmore TC; Howe JR; Korte JA; Dilley WG; Aine L; Aine E; Wells SA; Donis-Keller H
Genomics; 1991 Jan; 9(1):181-92. PubMed ID: 1672289
[TBL] [Abstract][Full Text] [Related]
7. Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIA.
Yang KP; Nguyen CV; Castillo SG; Samaan NA
Anticancer Res; 1990; 10(2B):527-33. PubMed ID: 1972009
[TBL] [Abstract][Full Text] [Related]
8. Allele loss on chromosome 10 and point mutation of ras oncogenes are infrequent in tumors of MEN 2A.
Okazaki M; Miya A; Tanaka N; Miki T; Yamamoto M; Motomura K; Miyauchi A; Mori T; Takai S
Henry Ford Hosp Med J; 1989; 37(3-4):112-5. PubMed ID: 2576939
[TBL] [Abstract][Full Text] [Related]
9. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.
Benn DE; Dwight T; Richardson AL; Delbridge L; Bambach CP; Stowasser M; Gordon RD; Marsh DJ; Robinson BG
Cancer Res; 2000 Dec; 60(24):7048-51. PubMed ID: 11156410
[TBL] [Abstract][Full Text] [Related]
10. Deletion mapping of chromosome 1p and 22q in pheochromocytoma.
Shin E; Fujita S; Takami K; Kurahashi H; Kurita Y; Kobayashi T; Mori T; Nishisho I; Takai S
Jpn J Cancer Res; 1993 Apr; 84(4):402-8. PubMed ID: 8514606
[TBL] [Abstract][Full Text] [Related]
11. Hereditary medullary thyroid carcinoma: genetic annalysis of three related syndromes. Groupe d'Etude des Tumeurs a Calcitonine.
Sobol H; Narod SA; Schuffenecker I; Amos C; Ezekowitz RA; Lenoir GM
Henry Ford Hosp Med J; 1989; 37(3-4):109-11. PubMed ID: 2576938
[TBL] [Abstract][Full Text] [Related]
12. [The multiple endocrine neoplasm type-IIb syndrome].
Kazeev KN; Lisnianskiĭ IE; Zaletaev DV; Kuratev LV; Avdeeva TF
Probl Endokrinol (Mosk); 1988; 34(6):45-7. PubMed ID: 2907132
[No Abstract] [Full Text] [Related]
13. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.
Andersen TI; Gaustad A; Ottestad L; Farrants GW; Nesland JM; Tveit KM; Børresen AL
Genes Chromosomes Cancer; 1992 Mar; 4(2):113-21. PubMed ID: 1373310
[TBL] [Abstract][Full Text] [Related]
14. Loss of genes on chromosome 22 in medullary thyroid carcinoma and pheochromocytoma.
Takai S; Tateishi H; Nishisho I; Miki T; Motomura K; Miyauchi A; Kato M; Ikeuchi T; Yamamoto K; Okazaki M
Jpn J Cancer Res; 1987 Sep; 78(9):894-8. PubMed ID: 2889715
[TBL] [Abstract][Full Text] [Related]
15. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q.
Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M
Genes Chromosomes Cancer; 2000 Mar; 27(3):244-51. PubMed ID: 10679913
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of 24 French families with multiple endocrine neoplasia type 2A.
Narod SA; Lavoué MF; Morgan K; Calmettes C; Sobol H; Goodfellow PJ; Lenoir GM
Am J Hum Genet; 1992 Sep; 51(3):469-77. PubMed ID: 1353939
[TBL] [Abstract][Full Text] [Related]
17. Linkage analysis of hereditary thyroid carcinoma with and without pheochromocytoma.
Narod SA; Sobol H; Nakamura Y; Calmettes C; Baulieu JL; Bigorgne JC; Chabrier G; Couette J; de Gennes JL; Duprey J
Hum Genet; 1989 Nov; 83(4):353-8. PubMed ID: 2572534
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis, management, and pathogenetic studies in medullary thyroid carcinoma syndrome.
Samaan NA; Yang KP; Schultz P; Hickey RC
Henry Ford Hosp Med J; 1989; 37(3-4):132-7. PubMed ID: 2576946
[TBL] [Abstract][Full Text] [Related]
19. Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours.
Nikiforova MN; Nikiforov YE; Biddinger P; Gnepp DR; Grosembacher LA; Wajchenberg BL; Fagin JA; Cohen RM
Clin Endocrinol (Oxf); 1999 Jul; 51(1):27-33. PubMed ID: 10468962
[TBL] [Abstract][Full Text] [Related]
20. Fine analysis of the short arm of chromosome 1 in sporadic and familial pheochromocytoma.
Opocher G; Schiavi F; Vettori A; Pampinella F; Vitiello L; Calderan A; Vianello B; Murgia A; Martella M; Taccaliti A; Mantero F; Mostacciuolo ML
Clin Endocrinol (Oxf); 2003 Dec; 59(6):707-15. PubMed ID: 14974911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
